Patents Assigned to CG and Associates
  • Methods of delivery of cetyl myristoleate
    Publication number: 20020176887
    Abstract: The invention provides novel and advantageous delivery devices for compositions of cetyl myristoleate. The delivery devices include transdermal delivery devices, suppositories, enteric coatings, and microencapsulation. Further provided are methods of treating diseases using the disclosed delivery devices. Diseases that can be treated with the devices include, but are not limited to, diseases associated with the inflammation of tissues, diseases associated with inflammatory conditions affecting joints, and autoimmune diseases.
    Type: Application
    Filed: July 8, 2002
    Publication date: November 28, 2002
    Applicant: CG and Associates
    Inventors: Gary Lord, Carol Lytle
  • Methods of delivery of cetyl myristoleate
    Patent number: 6417227
    Abstract: The invention provides novel and advantageous delivery devices for compositions of cetyl myristoleate. The delivery devices include transdermal delivery devices, suppositories, enteric coatings, and microencapsulation. Further provided are methods of treating diseases using the disclosed delivery devices. Diseases that can be treated with the devices include, but are not limited to, diseases associated with the inflammation of tissues, diseases associated with inflammatory conditions affecting joints, and autoimmune diseases.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: July 9, 2002
    Assignee: CG and Associates
    Inventors: Gary R. Lord, Carol D. Lytle